Celldex Therapeutics reported $-63857000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AbbVie USD 5.72B 1.98B Jun/2025
Amgen USD 2.66B 1.37B Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Celldex Therapeutics USD -63857000 1.12M Jun/2025
Glaxosmithkline GBP 2.44B 1.74B Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024